Creative Biolabs Supports mRNA Therapeutics Development with Frontier Technology
New York, USA – July 13, 2022 – The mRNA-based therapeutic field has attracted much attention in the past two years since the approval of mRNA vaccines, coupled with their efficacy and sales figures. Currently, mRNA technology is considered to have great potential in revolutionizing the future of vaccines, as well as the treatment of various infectious diseases and cancers.
To solve challenges that are unique to mRNA drug development, Creative Biolabs focuses on developing mRNA technology continuously. The following are some of the mRNA services and products that Creative Biolabs can provide.
Compared with enzymatic synthesis, the chemical synthesis of mRNA is more efficient and scalable. Additionally, it can solve a series of problems that occur throughout the enzymatic synthesis of mRNAs, such as transcriptional errors and insufficient purity. Chemical mRNA synthesis can be used in the development of mRNA vaccines, genome editing tools, and mRNA amplification-based diagnostics.
According to different requirements, Creative Biolabs offers customized chemical mRNA synthesis services to produce desired mRNAs. Moreover, Creative Biolabs supports a wide range of post-transcriptional modifications, various purification options, and an analytical service suite adapted to specific requirements.
The development of mRNA confronts delivery obstacles. Multifunctional mRNAs possess different clinical applications and therefore have specific delivery requirements.
Integrating cutting-edge platforms and substantial experience in delivery vehicles for mRNA, Creative Biolabs is able to develop highly stable and efficient delivery systems. Creative Biolabs provides a range of mRNA delivery vehicles, including lipid-based vectors, polymer-based vectors, and hybrid vectors, all of which are supported by frontier mRNA delivery technology.
mRNA drugs, such as mRNA vaccines, have become a promising research area, as antibody RNA is much safer and free from the risk of infection when activating the specific immune response.
Creative Biolabs is committed to providing a wide range of high-quality, high-purity, and high-stability antibody mRNA products. Creative Biolabs can design and customize the most suitable synthetic template according to the different research needs. Based on the different modification strategies, Creative Biolabs further classifies antibody mRNA products, including nucleoside modifications (e.g. N1-methyl-pseudo-UTP, 5-Methyl-CTP & Pseudo-UTP and Pseudo-UTP), 3′ end poly(A) length (e.g. 30 nt or 120 nt), and 5′ cap end types (e.g. Cap0 or Cap1).
Explore more mRNA-based services and products at https://mrna.creative-biolabs.com.
About Creative Biolabs
Based on the professional team and advanced technology, Creative Biolabs is dedicated to developing comprehensive mRNA services to meet the broad potential applications of mRNA.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://mrna.creative-biolabs.com
